Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating levocarnitine for protecting the liver during chemotherapy in various B-cell acute lymphoblastic leukemia and related lymphoid malign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma
• T-lymphoblastic Leukemia

Drugs mentioned

• LEVOCARNITINE (levocarnitine)

Snippet

Sponsor: Children's Oncology Group | Conditions: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 3 | Status: ACTIVE_NOT_RECRUITING